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The lower alkyl esters of p-hydroxybenzoic acid are officially listed in many drug com-
pendia and are commercially available under the names paraben, parasept, nipagin, nipasol,
etc. The literature on their uses and properties was reviewed by Back (1), MacDonald (2),
Neidig and Burrell (3), Sokol (4), and Aalto, Firman and Rigler (5). These compounds are
best known for their extensive use as preservatives for pharmaceuticals, cosmetics and
foods.
In 1939 Cershenfeld and Perlstein (6) laid down the criteria for the ideal preservative.
The first characteristic they listed was "effectiveness against all types of micro-organisms
causing decomposition". The alkyl p-hydroxybenzoates have fulfilled this requirement to
a significant degree and their action against bacteria and fungi has been proven. Inasmuch
as most of the studies on these compounds were concerned with their use as preservatives,
they were tested mainly against the contaminant fungi, such as penicillium, aspergillus,
mucor, rhizopus, trichoderma, etc. Pathogenic fungi were also utilized as test organisms
(7—11). In an attempt to achieve a more comprehensive picture of the activity of these
compounds against pathogenic fungi, the present study was undertaken.
MATRRIAL5 AN0 MRTIIOOS
The compounds tested were the methyl, propyl and hutyl esters of p-hydroxybcnzoic
acid as furnished by the C and M Pharmacal Company of Detroit, Michigan.
The fungal test organisms used were from the stock collection of pathogenic fungi of the
Department of Dermatology and Syphilology, University of Michigan Medical School.
The bacterial cultures were ohtained from the bacteriological laboratory of the University
of Michigan Hospital.
The degree of antifungal activity was determined hy the serial dilution agar slant method,
as described fully in a previous paper (12). Inasmuch as the compounds were difficult to
dissolve in water, acetone was used as solvent. The drug solutions were made up in proper
serial dilutions and added to the Sabouraud's dextrose agar medium in 1 per cent amounts
in such a way that the final concentrations of the drug in the agar medium in each series
were 1 mg. per ml., 0.1 mg. per ml., 0.01 mg. per ml. and 0.001 mg. per ml. medium. One
per cent acetone controls without the drug in the agar medium were set up. The media were
slanted in 5 ml. amounts.
In antibacterial experiments essentially the same procedure was followed. The medium
used was Difco brain heart infusion. Inoculation was done with a loopf ill from 36-hour
cultures. The cultures were left at 37°C and observed for turbidity after 48 hours.
The reading was set at the lowest concentration of drug at which complete inhibition of
growth first appeared.
The availability of the drug from its ointment form was also tested. Tho drug prepara-
tion with the following formula was provided by the C and M Pharmacal Company.
* From the Department of Dermatology and Syphilology, University of Michigan
Medical School.
t Department of Dermatology and Syphilology, Wayne University Medical School.
This study was supported by the Medical Research and Development Board, Office of
the Surgeon General, Department of the Army, under Contract No. DA-49-007-Md.
Received for publication January 16, 1956.
239
240 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Silicone oil (60,000 cs.) 30.0%
"Hydrophobic" starch 10.0%
Butyl parasept 0.2%
Propyl parasept 0.2%
Petrolatum, USP 100.0%
Uniform suspensions of the test organisms were made in melted agar medium which were
then plated and allowed to solidify. The test organisms were Trichophylon mentagrophytes
and Staphylococcus aureus, coagulase positive. The former was suspended in Sabouraud's
dextrose agar, and the latter in Difco brain heart infusion agar. Three tenths gram of the
ointment was placed at t.he center of the agar surface of each plate, and the zones of inhibi
TABLE I
A ntifun gal and antibacterial activity of p-hydroxybenzoic acid esters
Lowest effective concentration of drugs in mg per ml medium
Propyl
p-Hydroxy-
Methyl Propyl Butyl benzoate +
p-Hydroxy- p-Hydroxy- p-Hydroxy- Butylbenzoate benzoate benzoate p-Hydroxy
benzoate
(1:1)
Piedraiahortai 1.0 0.1 0.1 0.1
Trichosporon beigelii 1.0 0.1 0.1 0.1
Trichophyton mentagrophytes 1.0 0.1 0.1 0.1
Trichophyton rubrum 1.0 0.1 0.1 0.1
Trichophyton tonsurans 1.0 0.1 0.1 0.1
Trichophyton schoenleini 1.0 0.1 0.1 0.1
Trichophyton violaceum 1.0 0.1 0.1 0.1
Trichophyton ferrugineum 1.0 0.1 0.1 0.1
Trichophyton verrucosum var. ochraceum... 1.0 0.1 0.1 0.1
Trichophyton verrucosum var. discoides.... 1.0 0.1 0.1 0.1
Trichophyton verrucosum var. album 1.0 0.1 0.1 0.1
Trichophyton concentricum 1.0 0.1 0.1 0.1
Trichophyton megnini 1.0 0.1 0.1 0.1
Trichophyton gallinae 1.0 0.1 0.1 0.1
Microsporum gypseum 1.0 0.1 0.1 0.1
Microsporum canis 1.0 0.1 0.1 0.1
Microsporumaudouini 0.1 0.1 0.1 0.1
Epidermophyton floccosum 1.0 0.1 0.1 0.1
Cladosporiumwernecki 1.0 1.0 1.0 1.0
Hormodendrum pedrosoi 1.0 0.1 0.1 0.1
Hormodendrum compactum 1.0 0.1 0.1 0.1
Phialophora verrucosa 1.0 1.0 1.0 1.0
Monosporium apiospermum 1.0 1.0 0.1 0.1
Nocardiaasteroides 1.0 1.0 0.1 0.1
Candida albicans 1.0 1.0 1.0 1.0
Cryptococcus neoformans 1.0 1.0 0.1 0.1
Sporotrichum schencki 1.0 0.1 0.1 0.1
Blastomyces dermatitidis 0.1 0.1 0.1 0.1
Blastomyces brasiliensis 1.0 1.0 0.1 0.1
Histoplasmacapsulatum 1.0 0.1 0.1 0.1
Staphylococcus aureus, coagulase + >1.0 1.0 1.0 1.0
Streptococcus hemolyticus, H group 0.1 1.0 1.0 1.0
Escherichiacoli >1.0 1.0 >1.0 >1.0
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tion were measured at the end of the incubation periods. Controls with the ointment base
were set up.
RESULTS AND DISCUSSION
Table I shows the experimental results. Apparently, the proven activity of the p-hy-
droxvbenzoic acid esters against the non-pathogenic fungi extends to the pathogenic
species. The effective concentrations of the drugs as obtained under the present study
ranged from 0.1 mg. per ml. medium to 1 mg. per ml. medium, or 0.01 per cent to 0.1 per
Lent, respectively. These concentrations approximate those reported by other investigators.
The availability of the drugs from their ointment form was demonstrated by the appear-
ance of zones of inhibition in the pour plates with the ointment placed at the center. The
inhibition zone against Trichophyton mentagrophytes was 3.5 cm. in diameter, while that
against Staphylococcus anreus was 1.5 cm. The control plates did not show any inhibition.
Favorable results in the treatment of superficial mycotie infections with these compounds
in the form of ointments and solutions have been reported (13—18). It may he noted at. this
point that p-hydroxyhenzoic acid is an isomer of salicylic acid which is o-hydroxybenzoic
acid. More recently, these drugs have been suggested for use in attempts to control com-
plicating candidiasis during broad spectrum antibiotic therapy (11, 19, 20). In view of the
in vitro activity of the p-hydroxybenzoates against pathogenic fungi and their relative
innocuousness as borne out by their successful use as preservatives, it may be fruitful t.o
extend clinical studies with these chemicals on superficial fungus diseases and to further
pursue the suggestions of Wolf (8) and Delpiano and Ugazio (18) to try t.hem in the therapy
of systemic mycoses.
SUMMARY
The antifungal spectrum of the methyl, propvl and but esters of p-hydroxybenzoic
acid against pathogenic fungi was determined by the serial dilution agar slant method. The
lowest effective concentrations ranged from 0.1 mg. of drug per ml. medium to I mg. per ml.
medium, or 0.01 per cent to 0.1 per cent, respectively.
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